Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carolina Henriques Cavalcante"'
Autor:
Fernanda Lapa Campos, Janaina de Alcântara Lemos, Caroline Mari Ramos Oda, Juliana de Oliveira Silva, Renata Salgado Fernandes, Sued Eustaquio Mendes Miranda, Carolina Henriques Cavalcante, Geovanni Dantas Cassali, Danyelle M. Townsend, Elaine Amaral Leite, Andre Luis Branco de Barros
Publikováno v:
Polymers; Volume 14; Issue 22; Pages: 4905
Colorectal cancer has been considered a worldwide public health problem since current treatments are often ineffective. Irinotecan is a frontline chemotherapeutic agent that has dose-limiting side effects that compromise its therapeutic potential. Th
Autor:
Shirleide Santos Nunes, Danyelle M. Townsend, Carolina Henriques Cavalcante, Mônica Cristina de Oliveira, Elaine Amaral Leite, Isabela Costa César, Alice Ferretti, André Luís Branco de Barros, Valbert Nascimento Cardoso, Sávia Caldeira de Araújo Lopes, Renata Salgado Fernandes, Domenico Rubello
Liposomes are lipid vesicles widely used as nanocarriers in targeted drug delivery systems for therapeutic and/or diagnostic purposes. A strategy to prolong the blood circulation time of the liposomes includes the addition of a hydrophilic polymer po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1df66336a5c3b0d992ea74c0244b8f
https://europepmc.org/articles/PMC6361166/
https://europepmc.org/articles/PMC6361166/
Autor:
Elaine Amaral Leite, Juliana de Oliveira Silva, Ives Charlie-Silva, André Luís Branco de Barros, Geovanni Dantas Cassali, Caroline Mari Ramos Oda, Carolina Henriques Cavalcante, Lucas Antônio Miranda Ferreira, Bianca Helena Ventura Fernandes, Renata Salgado Fernandes
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 134, Iss, Pp 111076-(2021)
Doxorubicin (DOX) is an anthracycline antibiotic widely used in the treatment of cancer, however, it is associated with the occurrence of adverse reactions that limits its clinical use. In this context, the encapsulation of DOX in micelles responsive
Autor:
Carolina Henriques Cavalcante, Valbert Nascimento Cardoso, Marina Guedes Fonseca de Souza, Daniel Crístian Ferreira Soares, Sotirios Chondrogiannis, Domenico Rubello, Carolina A. Ferreira, Ana Carolina Maia, André Luís Branco de Barros, Gilson Andrade Ramaldes
Publikováno v:
Nuclear Medicine Communications. 37:775-782
Hydroxyapatite is used as a drug-delivery system for bone therapy applications because of its biocompatibility, bioactivity, and osteoconductive properties. In addition, hydroxyapatite nanoparticles (HApN) might be used as a theranostic probe. The ai